---
title: "ENWEI PHARMACEUTICAL released its 2024 annual performance, with a net profit attributable to the parent company of 37.4975 million yuan, a year-on-year decrease of 56.56%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236678197.md"
description: "ENWEI PHARMACEUTICAL released its 2024 annual report, with operating revenue of 812 million yuan, a year-on-year increase of 3.43%; net profit attributable to the parent company of 37.4975 million yuan, a year-on-year decrease of 56.56%; net profit excluding non-recurring gains and losses of 34.7296 million yuan, a year-on-year decrease of 52.80%; basic earnings per share of 0.3728 yuan/share. The company plans to distribute a cash dividend of 1.80 yuan (including tax) for every 10 shares"
datetime: "2025-04-20T09:14:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236678197.md)
  - [en](https://longbridge.com/en/news/236678197.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236678197.md)
generator: "portal-rs"
---

# ENWEI PHARMACEUTICAL released its 2024 annual performance, with a net profit attributable to the parent company of 37.4975 million yuan, a year-on-year decrease of 56.56%

According to the Zhitong Finance APP, ENWEI PHARMACEUTICAL (301331.SZ) released its annual report for 2024, reporting an operating income of 812 million yuan for the year, a year-on-year increase of 3.43%; the net profit attributable to shareholders of the listed company was 37.4975 million yuan, a year-on-year decrease of 56.56%; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 34.7296 million yuan, a year-on-year decrease of 52.80%; the basic earnings per share were 0.3728 yuan/share. It is proposed to distribute a cash dividend of 1.80 yuan (including tax) for every 10 shares

### Related Stocks

- [301331.CN](https://longbridge.com/en/quote/301331.CN.md)

## Related News & Research

- [Zaptec (OB:ZAP) Stock Price Reflects A Sharper Profit Engine](https://longbridge.com/en/news/296529847.md)
- [Orkla Non-GAAP EPS of NOK 1.60, revenue of NOK 16.7B](https://longbridge.com/en/news/296456178.md)
- [Vow ASA GAAP EPS of NOK 0.02, revenue of NOK 252.9M](https://longbridge.com/en/news/296331370.md)
- [Here's Why We're Watching NOA Lithium Brines' (CVE:NOAL) Cash Burn Situation](https://longbridge.com/en/news/296350687.md)
- [Komplett launches share buyback of up to 2 million shares for NOK 18 million](https://longbridge.com/en/news/296573485.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**